Monoclonal Antibodies in Cancer by Ghosh, A.K.
Br. J. Cancer (1986), 53, 149-152
BOOK REVIEWS
(Editorial Assistant: R. Tully)
Monoclonal Antibodies in Cancer. Edited by S. SELL
& R. REISFELD CLIFTON. Humana Press, xvii+428
pp, 1985, £68. ISBN 0 89603 068 7.
This multi-author book concerns the applications of
monoclonal antibodies in the study, diagnosis and
treatment of cancer. It represents the third volume
in a series on cancer markers and updates the vast
amount of information that is accumulating on the
use of monoclonal antibodies in the identification
of cancer antigens. The first chapter deals with a
brief review on the use of monoclonal antibodies in
the study of antigens associated with experimental
animal tumours with emphasis on areas of research
where these reagents have proven or potential
usage. The following chapters concentrate on the
human system and focus on individual human
tumour types, hormones, major histocompatibility,
complex antigens and oncofetal antigens. The
chapter on monoclonal carcinoembryonic antigen
(CEA) antibodies reviews the use of antibodies in
understanding the immunobiology of CEA and also
discusses how CEA antibodies can be used in
immunohistological diagnosis, tumour imaging and
immunotherapy. A chapter on melanoma describes
how monoclonal antibodies can be used as probes
for the molecular structure and biological function
ofmelanoma-associated antigens. These applications
of monoclonal antibodies in the molecular charac-
terisation of tumour antigens, in diagnosis and their
present status in cancer therapy are emphasized
throughout the remaining chapters. The relative
values of monoclonal versus polyclonal antibodies
are discussed. Problems associated with antigenic
heterogeneity and the use of antibody panels or
mixtures are also discussed. Review chapters cover
a range of tumour and cell types, including lung,
breast, kidney, prostate, brain tumours, T and B
cells and myeloid leukemia. The chapter on major
histocompatibility complex (MHC) antigens on
tumour cells focuses on the possible relationship
of expression of MHC antigens and neoplasia and
the potential involvement of these membrane glyco-
proteins in host-tumour reactions. Most of the
information reviewed relates to the murine system
but the potential relevance of the findings to human
tumour immunology is discussed. The last chapter
in the book is on human-human hybridomas and
discusses their potential application in defining the
humoral immune response of patients with cancer.
Although this book is more orientated towards
research workers, the clinical application of
monoclonal antibodies is well documented and it
contains useful information of value to all those
working in the field of tumour markers.
A.K. Ghosh
Precancerous Lesions of the Gastrointestinal Tract:
A Histological Classification. By: B.C. MORSON,
J.R. JASS & L.H. SOBIN. Bailliere Tindall, vii+175
pp, 1985, £22.50. ISBN 0 7020 1053 7.
Although this handbook is meant for the
histopathology reporting room, it can be strongly
recommended to the biologist in cancer research as
a source book, for two purposes: to illustrate how
pathologists work and to alert the biologist to
structural nuances in neoplasia.
The team from St Marks, commissioned by
WHO, write with authority with the specific object
of illustrating precancerous lesions of the
gastrointestinal tract to standardise nomenclature.
A few pages of text classify and describe the
lesions, but the 149 excellent, comparable
photomicrographs provide the substance. At this
price, it will be widely used.
If our biologist thought that precancerous
epithelial lesions took one or two forms, he should
study the book carefully with a sympathetic
pathologist on hand to translate the jargon. As it
makes no claim to discuss the lesions fully,
widespread assumptions will be revealed.
Curiously no definition of cancer is given
although this would specify one limit to the subject
under study. The authors launch straight into the
description. This is classical histopathology: the
structure of the biopsy is carefully assessed, and
then compared with biopsies (or their descriptions)
from earlier cases, whose outcome is known.
Experienced histopathologists become skilled at
foretelling the future in this way. Here the lesions
considered precancerous, collectively called
dysplasia, are shown although little is known yet of
the associated risk.
The classification by organ and pre-existing
disease might worry a biologist but suits the
pathologist. Each clinical decision is made against
its own background. But the accounts are uneven.
The cytological descriptions of dysplasia in
ulcerative colitis are very detailed (and well
illustrated) but sketchy in adenomas of the same
organ (and barely illustrated).